Press Releases

STEINHAUSEN, Switzerland, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Transocean Ltd. (NYSE:RIG) ("Transocean") today announced contract awards for two of its ultra-deepwater drillships in the U.S. Gulf. In aggregate, the fixtures represent approximately $550 million in firm contract backlog. The Deepwater Proteus was awarded a ten-well contract with an undisclosed operator in the U.S. Gulf. The estimated 700-day campaign is expected to contribute approximately $325 million in backlog and commence in the first quarter of 2027 in direct continuation of the rig’s current U.S. Gulf contract. The Deepwater Conqueror was awarded a five-well contract with an undisclosed operator in the U.S. Gulf. The es

Strategic acquisition of Perfectum strengthens Beeline Uzbekistan’s competitive position, expands spectrum resources and creates new opportunities for growth in 5G, broadband and digital Dubai, New York & Tashkent, [19 October 2026]– VEON Ltd. (NASDAQ:VEON), a global digital operator ("VEON" or the "Company"), today announces that it has agreed to acquire 100% of Rubicon Wireless, the mobile network operator trading under the "Perfectum" brand, a mobile network operator in Uzbekistan. The acquisition will bring complementary spectrum and network assets into VEON’s operations in Uzbekistan, strengthening Beeline Uzbekistan’s ability to deliver better connectivity, expand broadband access an

OptimUM-01 and OptimUM-02 data supports the broad potential of darovasertib plus crizotinib to drive meaningful clinical benefits for patients with metastatic uveal melanoma, irrespective of HLA-A*02:01 allele status or line of therapy OptimUM-01 data demonstrates encouraging clinical activity from darovasertib combined with crizotinib in both treatment-naïve (7.4 month PFS, 27.1 month mOS, n=13) and heavily pretreated HLA-A*02:01-positive metastatic uveal melanoma, including in 2L patients following tebentafuspTreatment-naïve patients in OptimUM-01 and OptimUM-02 demonstrate comparable ORR, PFS and DOR in HLA-A*02:01-positive and -negative patients and consistent improvements in ORR and PFS

About two-thirds of metros favor buyers or are moving that way, but higher rates are shrinking what a fixed monthly budget can buyAUSTIN, Texas, Oct. 19, 2026 /PRNewswire/ -- Buyers are gaining leverage in the U.S. housing market, but higher mortgage rates are cutting their purchasing power, according to the Realtor.com® Market Clock® report released today.  The national Realtor.com® Market Clock® reading has moved to 4 o'clock, late balanced and loosening toward buyers, moving from 3 o'clock last quarter. About two-thirds of metros now favor buyers outright or are moving in that direction. "The Market Clock® tool helps buyers and sellers understand their negotiating power by bringing togeth

CHICAGO, Oct. 19, 2026 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that it will launch Tungsten futures to meet rising demand for its metals complex, which registered record volume this year. Trading will start by early Q1 2027, pending all relevant regulatory reviews.  With annual production between 85,000 and 95,000 metric tons, the global tungsten market is worth over $20 billion based on current spot prices. It has been identified as a critical mineral by the U.S., the E.U., Japan, India and others. Tungsten has an active spot market but lacks a futures market. The contract will be financially settled based on the Fastmarkets assessment for tun

Perfect Corp. (NYSE:PERF) ("Perfect" or the "Company"), a leading artificial intelligence ("AI") company offering AI and augmented reality ("AR") powered solutions to beauty, fashion, photo and video creative industries, today announced that at an extraordinary general meeting held today, the Company’s shareholders voted in favor of, among other things, the proposal to authorize and approve the previously announced Agreement and Plan of Merger (the "Merger Agreement"), dated as of July 10, 2026, between the Company and ProjectNY, an exempted company with limited liability incorporated under the laws of the Cayman Islands controlled by Ms. Alice H. Chang ("Merger Sub"), the plan of merger re

Cleveland-Cliffs Inc. (NYSE:CLF) today reported third-quarter results for the period ended September 30, 2026. Third-Quarter Consolidated Results Revenues of $5.6 billion Steel shipments of 4.2 million net tons GAAP net income of $165 million Adjusted EBITDA2 of $612 million GAAP net income of $0.26 per diluted share and adjusted net income1 of $0.28 per diluted share Liquidity of $3.2 billion as of September 30, 2026 Third-quarter 2026 consolidated revenues were $5.6 billion, compared to $5.2 billion in the second quarter of 2026. For the third quarter of 2026, the Company recorded GAAP net income of $165 million, or $0.26 per diluted share, with an adjusted net in

Firm has financed and facilitated $230 billion, and its Strategic Investment Group has deployed $5 billion in equity investments, half of its initial $10 billion target One year after launching its $1.5 trillion Security and Resiliency Initiative (SRI), JPMorganChase today announced it has deployed $5 billion in equity investments through its Strategic Investment Group and financed and facilitated more than $230 billion to help strengthen the industries, supply chains and technologies that underpin long-term national security and economic resilience. As geopolitical dynamics intensify, energy demand rises and supply chain vulnerabilities continue to challenge economies around the world,

New data from four priority programs, including the GPC3x4-1BB bispecific antibody, CEA targeting ADC, CDK4 inhibitor, and brain-penetrant PRMT5 inhibitor underscore the depth of BeOne’s solid tumor pipeline Multiple TEVIMBRA abstracts reinforce breadth of evidence across lung and gastrointestinal cancers, including data in combination with ZIIHERA in HER2+ gastroesophageal cancer BeOne Medicines Ltd. (NASDAQ:ONC, HKEX: 06160, SSE: 688235)), a global oncology company, today announced that data from across its rapidly progressing solid tumor portfolio will be presented at the European Society for Medical Oncology (ESMO) Congress 2026 on October 23-27 in Madrid. Presentations will highlig

Advanced Energy (NASDAQ:AEIS), a global leader in highly engineered, precision power conversion, measurement, and control solutions, will report its third quarter 2026 financial results after the market closes on Monday, November 2, 2026. Management's quarterly conference call will be held the same day beginning at 4:30 p.m. Eastern Time. To participate in the live earnings conference call, please dial 877-407-0890 approximately ten minutes prior to the start of the meeting and an operator will connect you. International participants can dial +1-201-389-0918. A live webcast of the call will be available on the Investors page of the company's website at ir.advancedenergy.com in the Event

Ingram Micro Holding Corporation (NYSE:INGM) ("Ingram Micro" or the "Company") announced today that it will hold a conference call to discuss third quarter 2026 financial results on Thursday, October 29th, 2026, at 2:00 p.m. PT (5:00 p.m. ET). The Company plans to release its financial results after market close the same day. The call can be accessed at 877-407-9781 or 201-689-8796. A live webcast of the call can also be accessed at the Ingram Micro investor relations website at https://ir.ingrammicro.com. A webcast replay will be available at https://ir.ingrammicro.com. About Ingram Micro Ingram Micro (NYSE:INGM) is a leading technology company for the global information technology

NEW YORK, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Medallion Financial Corp. (NASDAQ:MFIN) ("Medallion" or the "Company"), a specialty finance company that originates and services loans in various consumer and commercial industries, along with offering loan-origination services to fintech strategic partners, today announced that the Company has entered into a purchase and settlement agreement (the "Purchase Agreement") with BIMIZCI Fund LLC ("BIMIZCI") and ZimCal Asset Management LLC ("ZimCal" and, together with BIMIZCI, the "Investor Parties"). Pursuant to the Purchase Agreement, the Company has agreed to repurchase from BIMIZCI trust preferred securities ("TruPS") with a liquidation amount of

VANCOUVER, British Columbia , Oct. 19, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (NASDAQ:ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced that Suzanne Monahan has been appointed Senior Vice President, Commercial and General Manager, Theravance Biopharma, effective immediately. Reporting directly to Kenneth Galbraith, Chair and Chief Executive Officer of Zymeworks, Ms. Monahan will lead Zymeworks’ commercial strategy and execution for YUPELRI® (revefenacin), the first and only once-daily, nebulized long-acting muscarinic antagonist (LAMA) approved in the U.S. for the

Dole plc (NYSE:DOLE) (the "Company") will announce its financial results for the third quarter of 2026 on Monday, November 9, 2026, prior to the market opening. The Company’s management will host a webcast on the same day at 8:00 a.m. Eastern Time.A presentation to accompany the discussion, along with a press release and other supplemental financial information, will be available at www.doleplc.com/investor-relations/financials.The live webcast and a replay after the event can be accessed at www.doleplc.com/investor-relations/events-and-presentations or directly at www.events.q4inc.com/attendee/145693531.About Dole plc:A global leader in fresh produce, Dole plc grows, markets, and distribute

In less than one year since the service launched in Ukraine, Kazakhstan and Bangladesh, the direct-to-device service has connected a combined 11 million people From Ukraine to Central Asia and South Asia, the service has the potential to reach more than 40 million people across VEON’s footprint Dubai, New York and Starbase, 19 October 2026 – VEON Ltd. (NASDAQ:VEON), a global digital operator, and Starlink Mobile today announced that more than 11 million unique VEON customers have now connected to the direct-to-device service at least once in locations where cell signal cannot reach. VEON customers can use satellite-ready apps, share location, and send messages via apps and SMS on their exis

DANBURY, CT, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Ethan Allen Interiors Inc. ("Ethan Allen" or the "Company") (NYSE:ETD) will release its financial and operational results for the fiscal 2027 first quarter ended September 30, 2026, after the stock market closes on Monday, November 9, 2026. Following the release, the Company will host a conference call at 5:00 p.m. Eastern Time to discuss these results. The conference call will be webcast live from the Company’s Investor Relations website at https://ir.ethanallen.com.   The following information is provided for those who would like to participate in the live conference call: U.S. Toll-Free:    877-705-2976International:     201-689-8798Confe

For three days only, fans can celebrate the return of Chocolate Original Glazed® with a limited-edition Taz™ dozen – available for just $5 with any dozen purchase Krispy Kreme® is spinning up even more Halloween mischief this week with the return of Chocolate Original Glazed® and the debut of the limited-edition Taz™ Chocolate Original Glazed® Dozen, available for three days only, Oct. 20-22, at participating shops across the U.S. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261019415480/en/For three days only, fans can celebrate the return of Chocolate Original Glazed® with a limited-edition Taz™ dozen – available for just

LOUISVILLE, Colo., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX), a leading diagnostics solutions company, today announced the addition of Digital Diagnostics to its Lung Diagnostics strategy, establishing the foundation for a multimodal diagnostic platform that combines blood-based biomarkers, imaging biomarkers, and artificial intelligence. The first product, a radiomics-based test for lung nodule risk assessment developed with Vanderbilt University and Vanderbilt Health, is designed to complement the Nodify Lung® portfolio and represents the next phase of innovation in lung diagnostics. Initial data for this new test will be presented at RSNA on December 3, 2026, and co

SAN DIEGO, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ:BLTE) ("Belite Bio®" or the "Company"), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it has received approval from Nasdaq to transfer the listing of its securities from the Nasdaq Capital Market to the Nasdaq Global Select Market. Trading on the Nasdaq Global Select Market will commence at the open of market on October 19, 2026, under the Company’s existing ticker symbol "BLTE." The Nasdaq Global Select Market is the highest of the three Nasdaq market tiers. The uplisting to this Ma

HOUSTON, Oct. 19, 2026 /PRNewswire/ -- Nutex Health, Inc. (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 28 state-of-the-art micro hospitals and hospital outpatient departments in 12 states and primary care-centric, risk-bearing physician networks, today announced that it plans to file its Form 10-Q for the third fiscal quarter ended Sept. 30, 2026, on Thursday, Nov. 5, 2026, after the market close. The Company will also issue a corresponding press release summarizing financial results on the same day. Nutex Health will host its earnings conference call on Friday, Nov. 6, 2026, at 9:30 a.m. CT to discuss the Company's financial performance and provide a bu